Paladin Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Paladin Wealth’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3	Closed	-$1.86K	–	215
2024 Q3	$1.86K	Buy	+3	New	+$1.78K	﹤0.01%	213

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paladin Wealth's TMO Position: Q4 2024 in Review

Paladin Wealth sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 3 shares — an estimated $1.86K sold.

Paladin Wealth first reported a position in TMO in Q3 2024 and held it in 1 quarter. The position peaked at $1.86K in Q3 2024. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

Paladin Wealth reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
Paladin Wealth sold 3 Thermo Fisher Scientific shares in Q4 2024, an estimated $1.86K.
Paladin Wealth first reported a position in Thermo Fisher Scientific in Q3 2024 and held it in 1 quarter.
Paladin Wealth's Thermo Fisher Scientific position peaked at $1.86K in Q3 2024.
2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Paladin Wealth's 13F filing for Q4 2024, filed 29 Jan 2025.